Literature DB >> 5996391

[Resuscitation in embolic and toxic complication caused by intravascular administration of a depot-penicillin].

G Clauberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5996391

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  15 in total

1.  Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells.

Authors:  Renier Myburgh; Jonathan D Kiefer; Norman F Russkamp; Chiara F Magnani; Nicolás Nuñez; Alexander Simonis; Surema Pfister; C Matthias Wilk; Donal McHugh; Juliane Friemel; Antonia M Müller; Burkhard Becher; Christian Münz; Maries van den Broek; Dario Neri; Markus G Manz
Journal:  Leukemia       Date:  2020-05-01       Impact factor: 11.528

2.  Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells.

Authors:  Bin Gu; Bing-Yu Shi; Xiang Zhang; Shi-Yuan Zhou; Jian-Hong Chu; Xiao-Jin Wu; Cheng-Cheng Fu; Hui-Ying Qiu; Yue Han; Su-Ning Chen; Lei Yu; Xiao Ma; De-Pei Wu
Journal:  Bone Marrow Transplant       Date:  2020-06-24       Impact factor: 5.483

3.  Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds.

Authors:  David K Y Zhang; Alexander S Cheung; David J Mooney
Journal:  Nat Protoc       Date:  2020-01-13       Impact factor: 13.491

Review 4.  Development of CAR-T cell therapies for multiple myeloma.

Authors:  Nico Gagelmann; Kristoffer Riecken; Christine Wolschke; Carolina Berger; Francis A Ayuk; Boris Fehse; Nicolaus Kröger
Journal:  Leukemia       Date:  2020-06-22       Impact factor: 11.528

5.  Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.

Authors:  Shunsuke Goto; Yukimi Sakoda; Keishi Adachi; Yoshitaka Sekido; Seiji Yano; Masatoshi Eto; Koji Tamada
Journal:  Cancer Immunol Immunother       Date:  2021-02-08       Impact factor: 6.968

Review 6.  Value and affordability of CAR T-cell therapy in the United States.

Authors:  Salvatore Fiorenza; David S Ritchie; Scott D Ramsey; Cameron J Turtle; Joshua A Roth
Journal:  Bone Marrow Transplant       Date:  2020-05-30       Impact factor: 5.483

Review 7.  [CAR T-cell therapy for children and adolescents with acute lymphatic leukemia].

Authors:  Peter Bader; Thomas Klingebiel
Journal:  Internist (Berl)       Date:  2021-05-05       Impact factor: 0.743

8.  CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.

Authors:  Kam Tong Leung; Chi Zhang; Kathy Yuen Yee Chan; Karen Li; John Tak Kit Cheung; Margaret Heung Ling Ng; Xiao-Bing Zhang; Tony Sit; Wayne Yuk Wai Lee; Wei Kang; Ka Fai To; Jasmine Wai Sum Yu; Toni Ki Fong Man; Han Wang; Kam Sze Tsang; Frankie Wai Tsoi Cheng; Grace Kee See Lam; Tin Wai Chow; Alex Wing Kwan Leung; Ting Fan Leung; Patrick Man Pan Yuen; Pak Cheung Ng; Chi Kong Li
Journal:  Leukemia       Date:  2019-10-17       Impact factor: 11.528

Review 9.  Next-generation CAR T cells to overcome current drawbacks.

Authors:  Stefan Lundh; Sayantan Maji; J Joseph Melenhorst
Journal:  Int J Hematol       Date:  2020-06-27       Impact factor: 2.490

Review 10.  The evolution of commercial drug delivery technologies.

Authors:  Ava M Vargason; Aaron C Anselmo; Samir Mitragotri
Journal:  Nat Biomed Eng       Date:  2021-04-01       Impact factor: 25.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.